The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

Report on how AI is redefining market landscape - The global effervescent tablet market size is estimated to grow by USD 4.80 billion from 2024-2028, according to Technavio. The market is estimated to ...

Signs and symptoms of serotonin syndrome include the ... aggravation by routine physical activity and association with nausea and/or photophobia and phonophobia. Previously it was called common ...

Anish Mistry, optometry director at Specsavers Nottinghamshire 2 Domiciliary Home Visits, on the value of providing care for vulnerable patients ...

Previously it was called common migraine 1.2 MA Recurrent disorder manifesting in attacks of reversible focal neurological symptoms that usually develop gradually over 5–20 min and last for less ...

With regards to the additional visual symptoms of VSS, floaters (n=348; 87%), afterimages (n=327; 82%) and photophobia (n=325; 81%) were the most common, with patients reporting an average of 6±2 ...